Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 2Plasma cell 1

Conditions

Leukemia, Myeloid, Acute 133Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Myelodysplastic Syndromes 111Leukemia, Lymphocytic, Chronic, B-Cell 101Lymphoma, Non-Hodgkin 97Hodgkin Disease 94Leukemia 85Multiple Myeloma 84Lymphoma 71Lymphoma, Mantle-Cell 66Lymphoma, Follicular 66Lymphoma, Large B-Cell, Diffuse 63Leukemia, Myelogenous, Chronic, BCR-ABL Positive 60Myeloproliferative Disorders 58Lymphoma, B-Cell, Marginal Zone 57Burkitt Lymphoma 52Leukemia, Myelomonocytic, Chronic 51Congenital Abnormalities 50Leukemia, Myeloid, Chronic-Phase 49Lymphoma, Large-Cell, Immunoblastic 45Leukemia, Myeloid, Accelerated Phase 42Hematologic Neoplasms 42Anemia, Refractory, with Excess of Blasts 40Graft vs Host Disease 39Primary Myelofibrosis 36Waldenstrom Macroglobulinemia 33Neoplasms, Plasma Cell 32Blast Crisis 32Lymphoma, T-Cell, Cutaneous 30Recurrence 29

Interventions

Cyclophosphamide 22blinatumomab 18Cytarabine 15fludarabine 13Azacitidine 12venetoclax 10fludarabine phosphate 10Rituximab 8Lenalidomide 7Dexamethasone 7Methotrexate 6Daunorubicin 6Mercaptopurine 5daratumumab 4Whole-Body Irradiation 4Vincristine 4Melphalan 4Idarubicin 4Etoposide 4Busulfan 4pembrolizumab 3obinutuzumab 3Radiotherapy 3Maintenance 3Immunotherapy, Adoptive 3Imatinib Mesylate 3Granulocyte Colony-Stimulating Factor 3Drug Therapy 3Cladribine 3Asparaginase 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasm, Residual × Mycophenolic Acid × Clear all
NCT03192397 2026-04-14

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Roswell Park Cancer Institute

Phase 1/2 Active not recruiting
35 enrolled 19 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Neoplasm, Residual

NCT03096782 2023-10-11

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

M.D. Anderson Cancer Center

Phase 2 Completed
6 enrolled 10 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Histiocytosis, Langerhans-Cell, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡